 Connection
Michael Kahn to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Michael Kahn has written about Carcinoma, Hepatocellular.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.159 |
|
|
|
-
Wong AM, Ding X, Wong AM, Xu M, Zhang L, Leung HH, Chan AW, Song QX, Kwong J, Chan LK, Man M, He M, Chen J, Zhang Z, You W, Lau C, Yu A, Wei Y, Yuan Y, Lai PB, Zhao J, Man K, Yu J, Kahn M, Wong N. Unique molecular characteristics of NAFLD-associated liver cancer accentuate ß-catenin/TNFRSF19-mediated immune evasion. J Hepatol. 2022 08; 77(2):410-423.
Score: 0.139
-
Delgado ER, Yang J, So J, Leimgruber S, Kahn M, Ishitani T, Shin D, Mustata Wilson G, Monga SP. Identification and characterization of a novel small-molecule inhibitor of ß-catenin signaling. Am J Pathol. 2014 Jul; 184(7):2111-22.
Score: 0.020
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|